搜索临床试验以:口服rucaparib
总计8245个结果
-
zr Pharma & GmbHFoundation Medicine; Myriad Genetics, Inc.完全的卵巢癌 | 输卵管癌 | 上皮性卵巢癌 | 腹膜癌美国, 西班牙, 加拿大, 澳大利亚, 英国, 法国
-
Sun Yat-sen UniversityShenzhen Yunding Information Technology Co., Ltd.招聘中
-
Cancer Research UK完全的乳腺癌 | 卵巢癌 | brca1突变携带者 | brca2突变携带者英国
-
University of ManitobaCanadian Foundation for Dental Hygiene Research and Education完全的
-
Ohio State University Comprehensive Cancer CenterImmunoGen, Inc.; Clovis Oncology, Inc.主动,不招人BRCA1基因突变 | BRCA2基因突变 | 叶酸受体α阳性 | 复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 复发性子宫体癌 | 复发性子宫浆液性癌 | 复发性子宫癌肉瘤 | 铂耐药卵巢癌美国
-
Shirley Ryan AbilityLabNorthwestern University; University of Colorado, Boulder完全的
-
Claude Bernard UniversityElsan; University of Nancy邀请报名
-
University of NottinghamUniversity Hospitals of Derby and Burton NHS Foundation Trust完全的
-
Cheng-Hsin General HospitalNational Taiwan University邀请报名
-
Kerecis Ltd.Tufts University School of Dental Medicine完全的膜龈畸形 - 角化组织不足
-
Eunice Kennedy Shriver National Institute of Child...终止
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)主动,不招人去势抵抗性前列腺癌 | IV 期前列腺癌 AJCC v8 | IVA 期前列腺癌 AJCC v8 | IVB 期前列腺癌 AJCC v8 | 转移性前列腺癌美国
-
Nordsjaellands HospitalUniversity of Copenhagen招聘中
-
CochlearAvania; Trium Clinical Consulting完全的
-
Medicines Development for Global HealthImperial College London; Phillip T. and Susan M. Ragon Foundation终止
-
University of CopenhagenNordsjaellands Hospital完全的
-
University of Washington主动,不招人BRCA1基因突变 | BRCA2基因突变 | 去势抵抗性前列腺癌 | 同源重组缺陷 | PSA 进展 | IV 期前列腺腺癌 AJCC v7 | 睾酮的去势水平 | ATM基因突变 | 前列腺癌骨转移 | PSA 水平大于或等于 2美国
-
Peking Union Medical College HospitalThe Second Hospital of Hebei Medical University; Peking University International Hospital; Fujian... 和其他合作者招聘中
-
St Vincent's University Hospital, IrelandPelvEx完全的
-
Mashhad University of Medical Sciences完全的